List of bibliographic references indexed by Maladie dégénérative
Number of relevant bibliographic references: 114.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
001066 (2013) |
William Reginold [Canada] ; Sarah Duff-Canning [Canada] ; Christopher Meaney [Canada] ; Melissa J. Armstrong [Canada] ; Susan Fox [Canada] ; Brandon Rothberg [Canada] ; Cindy Zadikoff [États-Unis] ; Nancy Kennedy [États-Unis] ; David Gill [États-Unis] ; Paul Eslinger [États-Unis] ; Fred Marshall [États-Unis] ; Mark Mapstone [États-Unis] ; Kelvin L. Chou [États-Unis] ; Carol Persad [États-Unis] ; Irene Litvan [États-Unis] ; Benjamin Mast [États-Unis] ; David Tang-Wai [Canada] ; Anthony E. Lang [Canada] ; Connie Marras [Canada] | Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease |
001528 (2012) |
Olena Babenko [Canada] ; Igor Kovalchuk [Canada] ; Gerlinde A. Metz [Canada] | Epigenetic programming of neurodegenerative diseases by an adverse environment |
001901 (2011) |
Sylvia Villeneuve [Canada] ; Jessica Rodrigues-Brazete [Canada] ; Steve Joncas [Canada] ; Ronald B. Postuma [Canada] ; Véronique Latreille [Canada] ; Jean-François Gagnon [Canada] | Validity of the Mattis Dementia Rating Scale to Detect Mild Cognitive Impairment in Parkinson's Disease and REM Sleep Behavior Disorder |
001923 (2011) |
C. Gibrat [Canada] ; F. Cicchetti [Canada] | Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases : THE NEUROBIOLOGY OF NEURODEGENERATIVE DISORDER: FROM BASIC TO CLINICAL RESEARCH |
001935 (2011) |
Shivraj S. Jhala [Canada] ; Alan S. Hazell [Canada] | Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism |
001962 (2011) |
Owen A. Ross [États-Unis] ; Nicola J. Rutherford [États-Unis] ; Matt Baker [États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Minerva M. Carrasquillo [États-Unis] ; Mariely Dejesus-Hernandez [États-Unis] ; Jennifer Adamson [États-Unis] ; MA LI [États-Unis] ; Kathryn Volkening [États-Unis, Canada] ; Elizabeth Finger [Canada] ; William W. Seeley [États-Unis] ; Kimmo J. Hatanpaa [États-Unis] ; Catherine Lomen-Hoerth [États-Unis] ; Andrew Kertesz [Canada] ; Eileen H. Bigio [États-Unis] ; Carol Lippa [États-Unis] ; Bryan K. Woodruff [États-Unis] ; David S. Knopman [États-Unis] ; Charles L. Iii White [États-Unis] ; Jay A. Van Gerpen [États-Unis] ; James F. Meschia [États-Unis] ; Ian R. Mackenzie [Canada] ; Kevin Boylan [États-Unis] ; Bradley F. Boeve [États-Unis] ; Bruce L. Miller [États-Unis] ; Michael J. Strong [Canada] ; Ryan J. Uitti [États-Unis] ; Steven G. Younkin [États-Unis] ; Neill R. Graff-Radford [États-Unis] ; Ronald C. Petersen [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Dennis W. Dickson [États-Unis] ; Rosa Rademakers [États-Unis] | Ataxin-2 repeat-length variation and neurodegeneration |
001F91 (2009) |
Ronald B. Postuma [Canada] ; Jean-Francois Gagnon [Canada] ; Melanie Vendette [Canada] ; Jacques Y. Montplaisir [Canada] | Idiopathic REM sleep behavior disorder in the transition to degenerative disease |
002068 (2009) |
S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France] | Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide |
002090 (2009) |
Sadayuki Hashioka [Canada] ; Andis Klegeris [Canada] ; Claudia Schwab [Canada] ; Patrick L. Mcgeer [Canada] | Interferon-γ-dependent cytotoxic activation of human astrocytes and astrocytoma cells |
002372 (2008) |
Michal Harciarek [Canada, Pologne] ; Andrew Kertesz [Canada] | The Prevalence of Misidentification Syndromes in Neurodegenerative Diseases |
002661 (2007) |
Frédéric Calon [Canada] ; Greg Cole [États-Unis] | Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases : Evidence from animal studies |
002930 (2006) |
Charles Ramassamy [Canada] | Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets |
002B37 (2005) |
Katie Wiltshire [Canada] ; Sheri Foster [Canada] ; Jeffrey A. Kaye [États-Unis] ; Brent J. Small [États-Unis] ; Richard Camicioli [Canada] | Corpus callosum in neurodegenerative diseases : Findings in Parkinson's disease |
002C94 (2004) |
Sandrine Thuret [Allemagne] ; Kambiz N. Alavian [Allemagne] ; Martin Gassmann [Suisse] ; C. Kent Lloyd [États-Unis] ; Simone M. Smits [Pays-Bas] ; Marten P. Smidt [Pays-Bas] ; Rüdiger Klein [Allemagne] ; Richard H. Dyck [Canada] ; Horst H. Simon [Allemagne] | The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta |
002D18 (2004) |
M. O. Poulter [Canada] ; K. B. Payne [Canada] ; J. P. Steiner [États-Unis] | Neuroimmunophilins: A novel drug therapy for the reversal of neurodegenerative disease? |
002D19 (2004) |
Richard Camicioli [Canada] ; Lisa Licis [Canada] | Motor impairment predicts falls in specialized Alzheimer care units |
002D27 (2004) |
Mark D. Berry [Canada] | Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders |
003060 (2002) |
Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
003581 (2000) |
Nancy J. Rothwell [Royaume-Uni] ; Giamal N. Luheshi [Canada] | Interleukin I in the brain : biology, pathology and therapeutic target |
003796 (1999) |
M. C. Evans [États-Unis] ; A. Pradhan [Canada] ; S. Venkatraman [États-Unis] ; W. H. Ojala [États-Unis] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring α, α-disubstituted amino acids |
003A54 (1998) |
P. H. Yu [Canada] ; X. Zhang [Canada] ; D. M. Zuo [Canada] ; C. T. Lai [Canada] ; K. Tieu [Canada] ; B. A. Davis [Canada] ; A. A. Boulton [Canada] | Aliphatic N-methylpropargylamines as potential neurorescue agents |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Maladie dégénérative"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i \
-Sk "Maladie dégénérative" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= PascalFr.i
|clé= Maladie dégénérative
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |